China SXT Pharmaceuticals SXTC
NASDAQ SXTC
$3.01 +0.20 (+7.12%)
At close: Sep 30, 2026 · 4:00 PM EDT

China SXT Pharmaceuticals (SXTC) Change in Receivables (2017 - 2019)

Updated

China SXT Pharmaceuticals (SXTC) reported Change in Receivables of $291,134 for FY2026 (year ended Mar 31, 2026), compared with -$257,085 in FY2025.

Analysis

China SXT Pharmaceuticals (SXTC) Change in Receivables (2017 - 2019) Analysis & Trends

Dating back to FY2017, China SXT Pharmaceuticals' Change in Receivables record includes 10 fiscal years.

  • The FY2026 figure ranks as the highest annual Change in Receivables since FY2023.
  • According to Business Quant data, Change in Receivables came in at -$257,085 in FY2025, -$321,422 in FY2024, $912,947 in FY2023 (+9.8%) and $831,473 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 China SXT Pharmaceuticals 39,500.23 -85.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 -1.81 Mn
Dec 31, 2018 384,434.00
Dec 31, 2017 -942,970.00
API Access

China SXT Pharmaceuticals Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=SXTC&period=max&api_key=YOUR_API_KEY